AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.91% | -88.51% | -83.44% | 40.86% | 14.81% |
| Total Depreciation and Amortization | -7.60% | 117.71% | -11.52% | -16.26% | -12.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.65% | 23.82% | 30.20% | 19.88% | 38.13% |
| Change in Net Operating Assets | -8.65% | -1.34% | 75.30% | -52.10% | -1.17% |
| Cash from Operations | 3.67% | -7.22% | 76.37% | 88.48% | 12.81% |
| Capital Expenditure | 48.15% | 46.85% | 43.55% | 47.05% | 33.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -237.68% | 53.58% | 64.63% | -3.01% | 37.55% |
| Cash from Investing | -102.97% | 51.58% | 52.74% | 17.34% | 35.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.79% | -7.78% | -63.79% | -- | -- |
| Issuance of Common Stock | -- | -- | -20.00% | -- | 444.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,061.54% | 98.13% | -91.31% | 91.81% | 128.09% |
| Foreign Exchange rate Adjustments | -119.90% | -102.80% | 231.25% | 76.39% | 64.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.11% | 44.20% | 58.97% | 413.97% | 18.62% |